Marketplace®
Every story is an economic story

Big Pharma is betting big on cancer drugs

Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer drugs. The merger is a sign that Big Pharma is betting big on cancer medications. […]

Big Pharma is betting big on cancer drugs
pxhere

Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer drugs. The merger is a sign that Big Pharma is betting big on cancer medications.

Click the audio player above to hear the full story.

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    5 hours ago
    25:45
  • Marketplace Morning Report
    13 hours ago
    7:02
  • Marketplace Tech
    18 hours ago
    7:01
  • This Is Uncomfortable
    5 days ago
    42:59
  • Million Bazillion
    14 days ago
    29:48
  • Make Me Smart
    5 months ago
    24:33